U.S. Pharmaceutical Preparation Market. Analysis And Forecast to 2025

IndexBox has just published a new report "U.S. Pharmaceutical Preparation Market. Analysis And Forecast to 2025" ( http://www.indexbox.co.uk/store/us-pharmaceutical-preparation-market-analysis-and-forecast-to-2020?utm_source=opr ).

The report provides on a comprehensive study of the U.S. pharmaceutical preparation market. It indicates the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains current data on the major players in the industry.

Countries coverage: the U.S.

Product coverage:
Pharmaceutical preparations, affecting neoplasms, the endocrine system, and metabolic diseases, for human use; Pharmaceutical preparations, acting on the central nervous system and the sense organs, for human use; Pharmaceutical preparations, acting on the cardiovascular system, for human use; Pharmaceutical preparations, acting on the respiratory system, for human use; Pharmaceutical preparations, acting on the digestive or the genito-urinary systems, for human use; Pharmaceutical preparations, acting on skin, for human use; Pharmaceutical preparations, vitamin, nutrient, and hematinic preparations, for human use; Pharmaceutical preparations, affecting parasitic and infective diseases, for human use (excluding diagnostics); Pharmaceutical preparations for veterinary use (including medicinal premixes and medicated pet care products; excluding pet flea and tick products), excluding diagnosticsIn vivo diagnostic substances; Pharmaceutical preparation manufacturing, nsk, total

Abstract:
In 2015, the value of pharmaceutical preparation production in the U.S. amounted to $153.7B, rising by +12.8% against the previous year level. Overall, the U.S. pharmaceutical preparation output pursued a noticeable growth from 2007 to 2015. The total output figures increased at an average annual rate of +2.7%. The trend pattern, however, indicated some noticable fluctuations throughout the analyzed period. The growth pace was the most rapid in 2015, when the output figure increased by +13% from the previous year level. In that year, the value of shipments of pharmaceutical preparation in the United States reached its maximum level and is likely to continue its growth in the immediate term.

Pharmaceutical preparations, affecting parasitic and infective diseases, for human use (excluding diagnostics) accounted for the highest share (22% in 2015) of U.S. pharmaceutical preparation manufacturing, leaving a considerable room for pharmaceutical preparations, acting on the central nervous system and the sense organs, for human use (21%). The other related products with less notable individual shares together comprised approx. 58% of the total output.

Companies mentioned:
Pfizer Inc.,
Merck & Co.,
Abbott Laboratories,
Abbvie Inc.,
Eli Lilly and Company,
Bristol-Myers Squibb Company,
Genentech,
Baxter International,
Allergan,
Biogen, Glaxosmithkline,
Celgene Corporation,
Hospira,
Alere,
Perrigo Company,
Mylan Inc.,
Regeneron Pharmaceuticals,
Novartis Corporation,
Alexion Pharmaceuticals,
Genzyme Corporation,
Zoetis,
Sanofi US Services,
Olympus Partners,
Valeant Pharmaceuticals International,
Merck Sharp & Dohme Corp.,
Glaxosmithkline Holdings (Americas),
Wyeth,
Astrazeneca Pharmaceuticals,
Actavis Inc.,
Alcon Laboratories Holding Corporation,
Roche Holdings

Data coverage:
• Pharmaceutical preparation market size;
• Pharmaceutical preparation production, value of shipments;
• Key market players and their profiles;
• Exports, imports and trade balance;
• Import and export prices;
• Forecast of the market dynamics in the medium term;
• Key industry statistics;
• Life cycle of the pharmaceutical preparation industry;
• Number of establishments and their locations;
• Employment data;
• Pharmaceutical preparation industry productivity.

Reasons to buy this report:
• Take advantage of the latest data;
• Find deeper insights into current market developments;
• Discover vital success factors affecting the market.

Source: http://www.indexbox.co.uk/store/us-pharmaceutical-preparation-market-analysis-and-forecast-to-2020?utm_source=opr

IndexBox is a leading market research publisher in the world. You can find more than 25,000 research reports in our web store, which cover global industries and regional markets. All the worldwide marketing data you need is at your fingertips.

Company Name: IndexBox
Contact Person: Kirill Bezverhi
Email: kirill.bezverhi@indexbox.co.uk
Phone: +44 20 3239 3063
Adress: United Kingdom, 44 Main Street, Douglas, South Lanarkshire, Scotland, ML11 0QW

This release was published on openPR.